Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #8 Nationally by U.S. News & World Report.
The purpose of this multi-center research study is to evaluate the effects of etrolizumab in pediatric patients with ulcerative colitis or Crohn’s disease. Researchers primarily will be measuring the pharmacokinetics – how the body processes the drug – and its side effects, while also monitoring its effects on inflammation caused by these conditions. Etrolizumab is designed to block the binding of certain white blood cells to the lining of the gastrointestinal tract, which is thought to reduce the inflammation caused by ulcerative colitis or Crohn’s disease.
Subject to certain exclusion criteria, this study is accepting patients of both genders, ages 4 through 17 years, diagnosed with moderate to severe ulcerative colitis or moderate to severe Crohn’s disease.
Boys and Girls: Ages 4 through 17 years
Participants will be randomly assigned into one of two groups. One will receive an injection of the study drug every 4 weeks and the other will receive the drug at twice the dosage level, but at 8-week intervals. In both groups, etrolizumab will be administered over a period of 16 weeks followed by an 8-week safety follow up period. During visits for injections, researchers will collect blood, urine and stool samples for analysis. At the end of 24 weeks, participants will have the option of continuing in a study extension in which they will receive the study drug every 4 weeks for a period of 108 weeks. When participants are no longer receiving etrolizumab they will be followed by the research team via telephone every 6 months for 2 years.
Visits: 4 to 6 over 16 weeks, plus an additional 27 for participants who join the study extension
Duration: About 2-1/2 years, or 4-1/2 years for those who join the study extension
F. Hoffman-La Roche Ltd.
Study Description at National Institutes of Health
Inflammatory Bowel Disease
David Keljo, MD
For more information about the study or enrollment, please contact:
Amy Bookser, RN
Kathleen Calabro RN, BSN
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to make a donation online.